Atrophic Age-related Macular Degeneration (AMD) Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma (CB-PRP): a Pilot Study - Trial NCT05706896
Access comprehensive clinical trial information for NCT05706896 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS and is currently Recruiting. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Timeline & Enrollment
N/A
Dec 14, 2022
Jun 10, 2023
Primary Outcome
Autofluorescence atrophy area changes in treated eyes compared with sham group,Autofluorescence atrophy area changes in treated eyes compared with sham group (1)
Summary
The objective of the study will be to evaluate the efficacy of intravitreal injections of
 Umbilical Cord Blood Platelet-rich Plasma (CB-PRP) in order to reduce or stabilize the
 atrophic progression in dry Age-related Macular Degeneration (AMD)
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05706896
Non-Device Trial